Aprea Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Aprea Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2020 to Q1 2024.
  • Aprea Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was -$7.98K.
  • Aprea Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$93.1K.
  • Aprea Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$25.7K, a 16.8% increase from 2019.
  • Aprea Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2019 was -$30.9K, a 735% decline from 2018.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$7.98K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2020 -$12.2K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.